FI913917A7 - 3-amidopyrazolderivat, foerfarande foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa. - Google Patents

3-amidopyrazolderivat, foerfarande foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa.

Info

Publication number: FI913917A7
Authority: FI; Finland
Prior art keywords: dessa; farmaceutiska; amidopyrazolderivat; och; foerfarande foer
Prior art date: 1990-08-20

Application number

FI913917A

Other languages

English (en)

Other versions

FI104170B (fi

FI104170B1 (fi

FI913917A0 (fi

Inventor

Robert Boigegrain

Danielle Gully

Francis Jeanjean

Jean-Charles Molimard

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-20

Filing date

1991-08-19

Publication date

1992-02-21

1991-08-19 Application filed by Sanofi Sa filed Critical Sanofi Sa

1991-08-19 Publication of FI913917A0 publication Critical patent/FI913917A0/fi

1992-02-21 Publication of FI913917A7 publication Critical patent/FI913917A7/fi

1999-11-30 Application granted granted Critical

1999-11-30 Publication of FI104170B publication Critical patent/FI104170B/fi

1999-11-30 Publication of FI104170B1 publication Critical patent/FI104170B1/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
- C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

FI913917A 1990-08-20 1991-08-19 Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi FI104170B1 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9010486A FR2665898B1 (fr)	1990-08-20	1990-08-20	Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR9010486		1990-08-20

Publications (4)

Publication Number	Publication Date
FI913917A0 FI913917A0 (fi)	1991-08-19
FI913917A7 true FI913917A7 (fi)	1992-02-21
FI104170B FI104170B (fi)	1999-11-30
FI104170B1 FI104170B1 (fi)	1999-11-30

Family

ID=9399742

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI913917A FI104170B1 (fi)	1990-08-20	1991-08-19	Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi

Country Status (31)

Country	Link
US (6)	US5420141A (fi)
EP (1)	EP0477049B1 (fi)
JP (1)	JP2694932B2 (fi)
KR (1)	KR100223074B1 (fi)
AR (1)	AR248133A1 (fi)
AT (1)	ATE187167T1 (fi)
AU (1)	AU646683B2 (fi)
BR (1)	BR9103550A (fi)
CA (4)	CA2166903C (fi)
CZ (1)	CZ281864B6 (fi)
DE (1)	DE69131813T2 (fi)
DK (1)	DK0477049T3 (fi)
ES (1)	ES2142798T3 (fi)
FI (1)	FI104170B1 (fi)
FR (1)	FR2665898B1 (fi)
GR (1)	GR3032732T3 (fi)
HU (2)	HU217435B (fi)
IE (1)	IE912932A1 (fi)
IL (1)	IL99225A (fi)
LT (1)	LT3520B (fi)
LV (1)	LV10434B (fi)
MX (1)	MX9203576A (fi)
MY (1)	MY121908A (fi)
NO (1)	NO300212B1 (fi)
NZ (1)	NZ239476A (fi)
PL (1)	PL169085B1 (fi)
PT (1)	PT98717B (fi)
RU (1)	RU2066317C1 (fi)
SG (1)	SG52322A1 (fi)
TW (1)	TW366337B (fi)
ZA (1)	ZA916583B (fi)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL104311A (en) *	1992-02-05	1997-07-13	Fujisawa Pharmaceutical Co	Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2713225B1 (fr) *	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
FR2713224B1 (fr) *	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) *	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2147504A1 (en) *	1992-11-02	1994-05-11	Prasun K. Chakravarty	Substituted phthalazinones as neurotensin antagonists
FR2711140B1 (fr) *	1993-10-12	1996-01-05	Sanofi Sa	1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
US6492411B1 (en)	1993-11-30	2002-12-10	G. D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US6716991B1 (en)	1993-11-30	2004-04-06	G. D. Searle & Co.	Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
ES2180233T3 (es) *	1993-11-30	2003-02-01	Searle & Co	Pirazolil bencenosulfonamidas sustituidas para uso en el tratamiento de la inflamacion.
US5466823A (en) *	1993-11-30	1995-11-14	G.D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides
FR2714057B1 (fr) *	1993-12-17	1996-03-08	Sanofi Elf	Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2722193B1 (fr) *	1994-07-08	1996-10-04	Sanofi Sa	Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant
FR2732967B1 (fr) *	1995-04-11	1997-07-04	Sanofi Sa	1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
US5756529A (en) *	1995-09-29	1998-05-26	G.D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
FR2741621B1 (fr) *	1995-11-23	1998-02-13	Sanofi Sa	Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2742148B1 (fr) *	1995-12-08	1999-10-22	Sanofi Sa	Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA9711102B (en) *	1996-12-16	1998-08-13	Yamanouchi Pharma Co Ltd	N-[(substituted 5-membered heteroaryl)carbonyl] guanidine derivative
US5837714A (en) *	1997-03-03	1998-11-17	Sanofi	Solid pharmaceutical dispersions
US6197787B1 (en)	1997-03-03	2001-03-06	Sanofi-Synthelabo	Pharmaceutical formulations containing poorly soluble drug substances
US5760056A (en) *	1997-03-03	1998-06-02	Sanofi Pharmaceuticals, Inc.	Pharmaceutical formulation
BR9808136A (pt) *	1997-03-03	2000-03-28	Sanofi Synthelabo	Formulações farmacêuticas contendo substâncias medicamentosas fracamente solúveis.
US5776987A (en) *	1997-03-03	1998-07-07	Sanofi Pharmaceuticals, Inc.	Pharmaceutical suspension formulation
JP2002504909A (ja) *	1997-06-13	2002-02-12	スミスクライン・ビーチャム・コーポレイション	新規な置換ピラゾールおよびピラゾリン化合物
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
EP1037639A4 (en)	1997-12-19	2002-04-17	Smithkline Beecham Corp	HETEROARYL-SUBSTITUTED IMIDAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
ES2221426T3 (es) *	1998-08-20	2004-12-16	Smithkline Beecham Corporation	Nuevos compuestos de triazol sustituidos.
WO2000025791A1 (en)	1998-11-04	2000-05-11	Smithkline Beecham Corporation	Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
US6191147B1 (en) *	1998-12-24	2001-02-20	Ppd Discovery, Inc.	Pyrazole compounds and uses thereof
FR2800375B1 (fr)	1999-11-03	2004-07-23	Sanofi Synthelabo	Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
FR2800372B1 (fr) *	1999-11-03	2001-12-07	Sanofi Synthelabo	Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant
AU1782301A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p39 kinase inhibitors
AU1783201A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
JP2003514899A (ja)	1999-11-23	2003-04-22	スミスクライン・ビーチャム・コーポレイション	ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４‐ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
US6759410B1 (en) *	1999-11-23	2004-07-06	Smithline Beecham Corporation	3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
JP4371295B2 (ja)	2000-05-19	2009-11-25	メルクセローノソシエテアノニム	医薬として活性な化合物およびその使用方法
BR0114829A (pt)	2000-10-23	2003-09-23	Smithkline Beecham Corp	Novos compostos
US6956052B2 (en)	2001-09-19	2005-10-18	Pharmacia Corporation	Substituted pyrazolyl compounds for the treatment of inflammation
JP2005507892A (ja)	2001-09-19	2005-03-24	ファルマシア・コーポレーション	炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物
DE10146867A1 (de) *	2001-09-24	2003-04-24	Bayer Ag	Tetrahydroisochinoline
CA2458661A1 (en) *	2001-09-27	2003-04-03	Applied Research Systems Ars Holding N.V.	Methods of increasing endogenous testosterone levels
AR038967A1 (es) *	2002-03-18	2005-02-02	Solvay Pharm Bv	Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina
AU2003265394A1 (en) *	2002-08-14	2004-03-03	Ppd Discovery, Inc.	Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
US6649638B1 (en)	2002-08-14	2003-11-18	Ppd Discovery, Inc.	Prenylation inhibitors and methods of their synthesis and use
AU2003265395A1 (en) *	2002-08-14	2004-03-03	Ppd Discovery, Inc.	Prenylation inhibitors and methods of their synthesis and use
MXPA05004115A (es) *	2002-10-18	2005-06-22	Pfizer Prod Inc	Ligandos del receptor cannabionoide y usos de los mismos.
US7129239B2 (en) *	2002-10-28	2006-10-31	Pfizer Inc.	Purine compounds and uses thereof
US7247628B2 (en) *	2002-12-12	2007-07-24	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
US7429581B2 (en)	2002-12-23	2008-09-30	Sanofi-Aventis Deutschland Gmbh	Pyrazole-derivatives as factor Xa inhibitors
EP1433788A1 (en) *	2002-12-23	2004-06-30	Aventis Pharma Deutschland GmbH	Pyrazole-derivatives as factor Xa inhibitors
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
JPWO2004069824A1 (ja) *	2003-02-07	2006-05-25	第一製薬株式会社	ピラゾール誘導体
US7176210B2 (en) *	2003-02-10	2007-02-13	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7145012B2 (en)	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) *	2003-04-23	2006-11-28	Pfizer Inc.	Cannabiniod receptor ligands and uses thereof
US7268133B2 (en) *	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
US20040214856A1 (en) *	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
CA2524397A1 (en) *	2003-05-07	2004-11-18	Pfizer Products Inc.	Cannabinoid receptor ligands and uses thereof
US7232823B2 (en)	2003-06-09	2007-06-19	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
US20040259887A1 (en) *	2003-06-18	2004-12-23	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
JP4681548B2 (ja)	2003-07-22	2011-05-11	アステックス・セラピューティクス・リミテッド	３，４−ジ置換１ｈ−ピラゾール化合物および、そのサイクリン依存性キナーゼ（ｃｄｋ）およびグリコーゲン・シンセターゼ・キナーゼ−３（ｇｓｋ−３）調節剤としての使用
EP1670460B1 (en) *	2003-10-10	2014-11-26	Bristol-Myers Squibb Company	Pyrazole derivatives as cannabinoid receptor modulators
TW200526641A (en) *	2003-12-26	2005-08-16	Daiichi Seiyaku Co	Amidopyrazole derivatives
KR20060131906A (ko) *	2004-02-20	2006-12-20	아스트라제네카 아베	Ｃｂ1 조절제로서 유용한 3-치환 1,5-디페닐피라졸 유도체
ITMI20041032A1 (it)	2004-05-24	2004-08-24	Neuroscienze S C A R L	Compositi farmaceutici
EP1762568A1 (en) *	2004-07-01	2007-03-14	Daiichi Pharmaceutical Co., Ltd.	Pyrazole derivatives
WO2006067443A1 (en) *	2004-12-23	2006-06-29	Astrazeneca Ab	Therapeutic agents
US8404718B2 (en)	2005-01-21	2013-03-26	Astex Therapeutics Limited	Combinations of pyrazole kinase inhibitors
RU2425677C2 (ru) *	2005-01-21	2011-08-10	Астекс Терапьютикс Лимитед	Соединения, предназначенные для использования в фармацевтике
TWI389690B (zh)	2005-03-25	2013-03-21	Glaxo Group Ltd	新穎化合物（一）
US7923465B2 (en)	2005-06-02	2011-04-12	Glenmark Pharmaceuticals S.A.	Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
WO2006133926A1 (en) *	2005-06-17	2006-12-21	Carex Sa	Pyrazole derivates as cannabinoid receptor modulators
GB0514738D0 (en) *	2005-07-19	2005-08-24	Astrazeneca Ab	Therapeutic agents
EP1993560B1 (en) *	2006-03-10	2011-12-28	Jenrin Discovery	Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
WO2008007123A2 (en) *	2006-07-14	2008-01-17	Astex Therapeutics Limited	Pharmaceutical compounds
GB0619611D0 (en) *	2006-10-04	2006-11-15	Ark Therapeutics Ltd	Compounds and their use
EP2121617B1 (en)	2006-12-18	2014-01-22	7TM Pharma A/S	Cb1 receptor modulators
US7977358B2 (en) *	2007-07-26	2011-07-12	Hoffmann-La Roche Inc.	Pyrazol derivatives
US7943653B2 (en) *	2007-08-13	2011-05-17	Janssen Pharmaceutica N.V.	Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
US8133904B2 (en) *	2007-09-07	2012-03-13	Jenrin Discovery, Inc.	Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
US20110009463A1 (en) *	2007-10-17	2011-01-13	Yuri Karl Petersson	Geranylgeranyl transferase inhibitors and methods of making and using the same
KR100917037B1 (ko) *	2007-11-01	2009-09-10	한국과학기술연구원	피라졸릴카르복스아미도알킬피페라진 유도체 및 이의제조방법
DE102009036604A1 (de)	2009-07-30	2011-02-03	Aicuris Gmbh & Co. Kg	Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung
WO2011156557A2 (en) *	2010-06-11	2011-12-15	Thomas James B	Compounds active at the neurotensin receptor
CN102250006B (zh) *	2011-05-12	2014-03-05	范如霖	3-吡唑羧酸酰胺类化合物、其制备方法及其在制备作为cb1受体抑制剂药物中的应用
EP2740726A1 (en) *	2012-12-07	2014-06-11	3B Pharmaceuticals GmbH	Neurotensin receptor ligands
WO2015148465A1 (en) *	2014-03-25	2015-10-01	Research Triangle Institute	Pyrazole compounds selective for neurotensin 2 receptor
MA39999A (fr) *	2014-06-06	2015-12-10	Res Triangle Inst	Agonistes du récepteur de l'apeline (apj) et leurs utilisations
RU2021133849A (ru) *	2015-12-09	2022-03-21	Рисерч Трайэнгл Инститьют	Улучшенные агонисты апелинового рецептора (apj) и их использование
EP3279197A1 (en) *	2016-08-03	2018-02-07	Friedrich-Alexander-Universität Erlangen-Nürnberg	Diagnosis, treatment and prevention of neurotensin receptor-related conditions
TWI805699B (zh)	2018-03-01	2023-06-21	日商日本煙草產業股份有限公司	甲基內醯胺環化合物及其用途
AR114465A1 (es)	2018-04-04	2020-09-09	Japan Tobacco Inc	Compuestos de pirazol sustituidos con heteroarilo y su utilización farmacéutica
EP4021447A4 (en) *	2019-08-29	2023-10-11	Research Triangle Institute	METHODS AND USES FOR APELIN RECEPTOR AGONISTS

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4134987A (en) *	1976-01-14	1979-01-16	Huppatz John L	Compounds and compositions
EP0068806A3 (en) *	1981-06-26	1983-08-10	Warner-Lambert Company	Basic acyl amides of (5-amino-1,3-dialkylpyrazol-4-yl)(aryl)methanones, processes for their production, and pharmaceutical compositions containing such compounds
US4495195A (en) *	1982-11-01	1985-01-22	Eli Lilly And Company	Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use
DE3332633A1 (de) *	1983-09-09	1985-04-04	Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München	Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
IL73419A (en) *	1983-11-07	1988-02-29	Lilly Co Eli	1h-pyrazole-4-(thio)carboxamide derivatives,their preparation and herbicidal compositions containing them
JPS611651A (ja) *	1984-06-12	1986-01-07	Toyama Chem Co Ltd	Ｎ−アシル酸性アミノ酸ジアミド類およびその製造法並びにそれらを含有する抗潰瘍剤
BR8506974A (pt) *	1984-10-29	1986-12-23	Sumitomo Chemical Co	Derivado pirazolcarboxamida,processo para o seu preparo e fungicida contendo o mesmo como substancia atuante
JPH0678342B2 (ja) *	1986-01-07	1994-10-05	三共株式会社	新規マクロライド化合物
US4792565A (en) *	1986-04-24	1988-12-20	Mitsui Toatsu Chemicals, Inc.	Pyrazolecarbonylamine derivatives and agricultural and horticultural fungicides containing said compounds
US4826868A (en) *	1986-05-29	1989-05-02	Ortho Pharmaceutical Corporation	1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
US4916142A (en) *	1987-02-02	1990-04-10	Boc, Inc.	N-heterocyclic-N-(4-piperidinyl)amides and pharmaceutical compositions and their use as analgesics
US4954506A (en) *	1987-02-02	1990-09-04	Boc, Inc.	N-heterocyclic-N-(4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
US4791112A (en) *	1987-02-02	1988-12-13	The Boc Group, Inc.	N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
US4912109A (en) *	1987-02-02	1990-03-27	Boc, Inc.	N-heterocyclic-N-(4-piperidinyl) amides and pharmaceutical compositions and methods employing such compounds
JPS6425763A (en) *	1987-04-24	1989-01-27	Mitsubishi Chem Ind	Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
US4971978A (en) *	1987-09-21	1990-11-20	Nadzan Alex M	Derivatives of D-glutamic acid and D-aspartic acid
WO1989005300A1 (en) *	1987-11-30	1989-06-15	E.I. Du Pont De Nemours And Company	Heterocyclic pyrazoline carboxanilides
JP2861104B2 (ja) *	1988-10-14	1999-02-24	三菱化学株式会社	ピラゾールアミド類およびこれを有効成分とする殺虫、殺ダニ剤
WO1990014347A1 (fr) *	1989-05-24	1990-11-29	Nippon Shinyaku Co., Ltd.	Derives d'indole et medicament

1990
- 1990-08-20 FR FR9010486A patent/FR2665898B1/fr not_active Expired - Fee Related
1991
- 1991-08-17 HU HU750/91A patent/HU217435B/hu unknown
- 1991-08-19 IE IE293291A patent/IE912932A1/en not_active IP Right Cessation
- 1991-08-19 RU SU5001452/04A patent/RU2066317C1/ru not_active IP Right Cessation
- 1991-08-19 TW TW080106546A patent/TW366337B/zh not_active IP Right Cessation
- 1991-08-19 NO NO913234A patent/NO300212B1/no unknown
- 1991-08-19 IL IL9922591A patent/IL99225A/en not_active IP Right Cessation
- 1991-08-19 BR BR919103550A patent/BR9103550A/pt not_active Application Discontinuation
- 1991-08-19 FI FI913917A patent/FI104170B1/fi active
- 1991-08-19 PL PL91291463A patent/PL169085B1/pl not_active IP Right Cessation
- 1991-08-19 PT PT98717A patent/PT98717B/pt not_active IP Right Cessation
- 1991-08-19 AR AR91320430A patent/AR248133A1/es active
- 1991-08-20 MY MYPI91001513A patent/MY121908A/en unknown
- 1991-08-20 CA CA002166903A patent/CA2166903C/en not_active Expired - Fee Related
- 1991-08-20 CA CA002049514A patent/CA2049514C/en not_active Expired - Fee Related
- 1991-08-20 CA CA002166902A patent/CA2166902C/en not_active Expired - Fee Related
- 1991-08-20 NZ NZ239476A patent/NZ239476A/xx not_active IP Right Cessation
- 1991-08-20 DK DK91402269T patent/DK0477049T3/da active
- 1991-08-20 CZ CS912574A patent/CZ281864B6/cs not_active IP Right Cessation
- 1991-08-20 AU AU82596/91A patent/AU646683B2/en not_active Ceased
- 1991-08-20 CA CA002166901A patent/CA2166901C/en not_active Expired - Fee Related
- 1991-08-20 SG SG1996002749A patent/SG52322A1/en unknown
- 1991-08-20 AT AT91402269T patent/ATE187167T1/de not_active IP Right Cessation
- 1991-08-20 JP JP3208108A patent/JP2694932B2/ja not_active Expired - Fee Related
- 1991-08-20 DE DE69131813T patent/DE69131813T2/de not_active Expired - Fee Related
- 1991-08-20 EP EP91402269A patent/EP0477049B1/fr not_active Expired - Lifetime
- 1991-08-20 ES ES91402269T patent/ES2142798T3/es not_active Expired - Lifetime
- 1991-08-20 ZA ZA916583A patent/ZA916583B/xx unknown
- 1991-08-20 KR KR1019910014358A patent/KR100223074B1/ko not_active Expired - Fee Related
1992
- 1992-06-26 MX MX9203576A patent/MX9203576A/es unknown
1993
- 1993-02-25 LV LVP-93-138A patent/LV10434B/en unknown
- 1993-06-15 LT LTIP656A patent/LT3520B/lt not_active IP Right Cessation
- 1993-09-13 US US08/119,830 patent/US5420141A/en not_active Expired - Lifetime
1995
- 1995-02-24 US US08/393,829 patent/US5635526A/en not_active Expired - Fee Related
- 1995-02-27 US US08/394,756 patent/US5616592A/en not_active Expired - Fee Related
- 1995-02-27 US US08/394,757 patent/US5607958A/en not_active Expired - Fee Related
- 1995-06-30 HU HU95P/P00632P patent/HU211970A9/hu unknown
1996
- 1996-12-31 US US08/775,150 patent/US5744493A/en not_active Expired - Fee Related
1997
- 1997-01-02 US US08/778,105 patent/US5744491A/en not_active Expired - Fee Related
2000
- 2000-02-23 GR GR20000400431T patent/GR3032732T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP2694932B2 (ja)	1997-12-24
EP0477049A1 (fr)	1992-03-25
DE69131813T2 (de)	2000-05-31
DE69131813D1 (de)	2000-01-05
AU646683B2 (en)	1994-03-03
FI104170B (fi)	1999-11-30
JPH04244065A (ja)	1992-09-01
SG52322A1 (en)	1998-09-28
CA2166901C (en)	1999-01-26
LTIP656A (en)	1995-01-31
US5616592A (en)	1997-04-01
MY121908A (en)	2006-03-31
CA2049514C (en)	1997-02-25
EP0477049B1 (fr)	1999-12-01
HU211970A9 (en)	1996-01-29
HK1005136A1 (en)	1998-12-24
CS257491A3 (en)	1992-06-17
US5635526A (en)	1997-06-03
CZ281864B6 (cs)	1997-03-12
CA2049514A1 (en)	1992-02-21
PL291463A1 (en)	1992-07-13
NZ239476A (en)	1993-11-25
NO300212B1 (no)	1997-04-28
HUT59106A (en)	1992-04-28
RU2066317C1 (ru)	1996-09-10
NO913234L (no)	1992-02-21
US5744491A (en)	1998-04-28
AR248133A1 (es)	1995-06-30
CA2166903C (en)	1998-09-01
HU217435B (hu)	2000-01-28
KR100223074B1 (ko)	1999-10-15
LT3520B (en)	1995-11-27
US5744493A (en)	1998-04-28
ES2142798T3 (es)	2000-05-01
US5420141A (en)	1995-05-30
PT98717B (pt)	1999-01-29
CA2166901A1 (en)	1992-02-21
GR3032732T3 (en)	2000-06-30
MX9203576A (es)	1992-07-01
AU8259691A (en)	1992-02-27
NO913234D0 (no)	1991-08-19
PL169085B1 (pl)	1996-05-31
KR920004354A (ko)	1992-03-27
CA2166903A1 (en)	1992-02-21
TW366337B (en)	1999-08-11
LV10434A (lv)	1995-02-20
IE912932A1 (en)	1992-02-26
BR9103550A (pt)	1992-04-07
IL99225A0 (en)	1992-07-15
FI104170B1 (fi)	1999-11-30
US5607958A (en)	1997-03-04
PT98717A (pt)	1992-07-31
DK0477049T3 (da)	2000-04-25
FR2665898A1 (fr)	1992-02-21
ATE187167T1 (de)	1999-12-15
HU912750D0 (en)	1992-01-28
FR2665898B1 (fr)	1994-03-11
LV10434B (en)	1995-10-20
ZA916583B (en)	1992-05-27
CA2166902C (en)	1999-01-19
IL99225A (en)	1995-10-31
CA2166902A1 (en)	1992-02-21
FI913917A0 (fi)	1991-08-19

Publication	Publication Date	Title
FI913917A7 (fi)	1992-02-21	3-amidopyrazolderivat, foerfarande foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa.
FI916025A7 (fi)	1992-06-22	Doserings- och spraypump foer matning av flytande, laogviskoesa och pastaformiga aemnen.
FI912615A7 (fi)	1991-12-02	Foerfarande och anordning foer kontinuerlig torkning av traespaon, traefibrer och annat loesgods.
FI911936A7 (fi)	1991-10-28	Bensimidazolderivat, deras framstaellning och anvaendning.
FI913703L (fi)	1992-02-04	Hydreringskatalysatorkomposition, framstaellning och anvaendning av denna.
FI911211L (fi)	1991-09-14	Romboedriskt kalciumkarbonat och accelererat, termiskt aoldringsfoerfarande foer framstaellning daerav.
FI912379L (fi)	1991-11-19	Eldfast, vattenbestaendigt och syrafast bindemedel.
FI913503A7 (fi)	1992-01-24	Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI911584L (fi)	1991-10-05	Substituerade azoler, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI910751A7 (fi)	1991-12-21	Smoerjmedel, tillsatsaemnen av smoerjmedel och smoerjningsfoerfaranden foer oljebassmorda alkoholfoerbrukande sprutfoerbraenningsmotorer.
FI910311A0 (fi)	1991-01-21	Kalorifattiga, icke-kariogena aetbara kompositioner och foerfarande foer deras framstaellning.
FI914275L (fi)	1992-03-25	Bensimidazolderivat, framstaellning och anvaendning av dessa.
FI915381L (fi)	1992-05-17	Substituerade azoler, foerfarande foer framstaellning av dessa och deras anvaendning.
FI910440A0 (fi)	1991-01-30	Alkenylgrupper innehaollande siloxankopolymerer, deras framstaellning och anvaendning.
FI910368L (fi)	1991-07-26	Foerfarande foer framstaellning av traekompositionskivor, foerpresstaetningskompositioner och anvaendning av desamma.
FI914182A0 (fi)	1991-09-04	Maetningsfoerfarande foer magnetfaelt, maetningsapparat foer magnetfaelt, visningsfoerfarande foer magnetfaelt och visningsapparat foer magnetfaelt.
FI910032L (fi)	1991-07-05	Mikrofibrer bestaoende av syndiotaktiska vinylaromatiska polymerer, mikrofibermattor och smaeltblaosningsprocess foer framstaellning av dessa.
FI912223A0 (fi)	1991-05-08	Katalytkompositioner och polymeriseringsfoerfarande, hexakisfosfiner och hexahalogenfoereningar.
FI914776L (fi)	1992-04-13	Inhibitorer foer bildning av tumoernekrosfaktor, foerfarande foer deras framstaellning och anvaendning daerav.
FI903951A7 (fi)	1991-07-17	Foerfarande framstaellning, och anordning foer foerverkligande av foerfarandet.
FI914114L (fi)	1992-06-29	Jodinerade, icke-joniserade foereningar, foerfarande foer deras framstaellning och dessa innehaollande kontrastmedel.
FI911603A0 (fi)	1991-04-03	Foerfarande foer framstaellning av 2 -deoxi-d-treopentofuranosider, mellanprodukter foer deras framstaellning och deras anvaendning.
FI902611A0 (fi)	1990-05-25	Arkivlaoda foer loesa dokument, magasin och prosyrer.
FI911084A0 (fi)	1991-03-04	5-fenyl-1h-pyrazol-4 -propionsyraderivator, framstaellning och anvaendning av desamma.
FI904542A7 (fi)	1992-03-15	Kopplingsfotsystem foer ytfogningskomponenter, ytfogningskomponent och monteringsfoerfarande foer dessa.

Legal Events

Date	Code	Title	Description
2005-01-14	PC	Transfer of assignment of patent	Owner name: SANOFI-AVENTIS